Trading Members of the Exchange are hereby informed that effective from June 27, 2008, the equity shares of Bafna Pharmaceuticals Ltd (Scrip Code: 532989) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no 20080626-3 dated June 27, 2008.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment